by Innovation Center of NanoMedicine Glucose-PEGylated avelumab prevented the growth of glioblastoma. Credit: 2021 Innovation Center of NanoMedicine Multi-institutional researchers have succeeded in efficiently delivering an immune checkpoint inhibitor (ICI) into the mouse brain, confirming its high efficacy and specificity in treating orthotopically transplanted mice with glioblastoma (GBM). The research was published in Nature Biomedical Engineering....
